Skip to content

SG&A at other companies

LifeStance Health Group logo
LifeStance Health GroupLFST
$100.33M+6.2%
CVRx, Inc. logo
CVRx, Inc.CVRX
$21.96M+3.4%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$318.5M+15.2%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$5M+22.4%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$134.91M+1.5%
LivaNova logo
LivaNovaLIVN
$143.57M+11.2%

Segments

By segment

See full
Clinical Services$7.88M-0.6%
Medical Device$7.42M-15.1%

Other financials

Income statement

See full
Revenue$34.5M+7.8%
Gross profit$16.2M+2.6%
Operating income-$9.0M+18.3%
Net income-$10.8M+14.9%
EPS (diluted)-$0.16+23.8%

Balance sheet

See full
Cash & equivalents$13.2M-34.7%
Total debt$85.4M+3.5%
Total equity$13.3M-62.6%
Total assets$125.4M-11.7%

Cash flow

See full
Operating cash flow-$9.4M+44.6%
CapEx$197.0K-10.0%
Free cash flow-$9.6M+44.1%

Valuation

See full
Market cap$90.46M-56.2%
Enterprise value$162.64M-42.0%
P/S0.6×-1.3×

Profitability

See full
Gross margin48%-15.6pp
Operating margin-19.4%-6.9pp
Net margin-24.5%-8.7pp
FCF margin-9.4%-4.1pp

Returns & leverage

See full
Return on equity-152.4%-1.4pp
Debt / equity6.4×+4.1×
Current ratio1.7×-0.8×

Questions, answered.

What does SG&A mean?
Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.